XML 27 R14.htm IDEA: XBRL DOCUMENT v3.5.0.2
Valuation
9 Months Ended
Sep. 30, 2016
Fair Value Disclosures [Abstract]  
Valuation
Valuation
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at September 30, 2016:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
50,000

 
$

 
$

 
$
50,000

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
958,193

 
$
19,824

 
$
978,017

U.S. Treasury securities
 

 
5,373

 

 
5,373

Private label residential mortgage-backed securities
 

 
73,470

 
81,945

 
155,415

Private label commercial mortgage-backed securities
 

 

 
36,945

 
36,945

Commercial mortgage loans
 

 

 
56,969

 
56,969

Residential mortgage loans
 

 

 
44,075

 
44,075

Collateralized loan obligations
 

 

 
28,403

 
28,403

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
119,099

 
119,099

Corporate debt
 

 

 
56,317

 
56,317

Real estate owned
 

 

 
3,584

 
3,584

Private corporate equity investments
 

 

 
15,518

 
15,518

Total investments, at fair value
 

 
1,037,036

 
462,679

 
1,499,715

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
5,857

 
5,857

Credit default swaps on corporate bond indices
 

 
15,849

 

 
15,849

Credit default swaps on corporate bonds
 

 
2,759

 

 
2,759

Credit default swaps on asset-backed indices
 

 
20,972

 

 
20,972

Interest rate swaps
 

 
11,581

 

 
11,581

Total return swaps
 

 
1

 
196

 
197

Options
 

 
2

 

 
2

Futures
 
14

 

 

 
14

Warrants
 

 

 
7,586

 
7,586

Total financial derivatives–assets, at fair value
 
14

 
51,164

 
13,639

 
64,817

Repurchase agreements
 

 
165,048

 

 
165,048

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$
14

 
$
1,253,248

 
$
476,318

 
$
1,729,580

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(511,754
)
 
$

 
$
(511,754
)
Government debt
 

 
(98,604
)
 

 
(98,604
)
Corporate debt
 

 

 
(39,187
)
 
(39,187
)
Common stock
 
(29,476
)
 

 

 
(29,476
)
Total investments sold short, at fair value
 
(29,476
)
 
(610,358
)
 
(39,187
)
 
(679,021
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(9,594
)
 

 
(9,594
)
Credit default swaps on corporate bonds
 

 
(6,896
)
 

 
(6,896
)
Credit default swaps on asset-backed indices
 

 
(3,085
)
 

 
(3,085
)
Credit default swaps on asset-backed securities
 

 

 
(262
)
 
(262
)
 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Interest rate swaps
 
$

 
$
(18,299
)
 
$

 
$
(18,299
)
Total return swaps
 

 
(84
)
 
(1,223
)
 
(1,307
)
Options
 

 
(3
)
 

 
(3
)
Futures
 
(93
)
 

 

 
(93
)
Forwards
 

 
(277
)
 

 
(277
)
Total financial derivatives–liabilities, at fair value
 
(93
)
 
(38,238
)
 
(1,485
)
 
(39,816
)
Guarantees(1)
 

 

 
(150
)
 
(150
)
Total investments sold short, financial derivatives–liabilities, and guarantees, at fair value
 
$
(29,569
)
 
$
(648,596
)
 
$
(40,822
)
 
$
(718,987
)

(1)
Included in Other liabilities on the Consolidated Statement of Assets, Liabilities, and Equity.
There were no transfers of financial instruments between Level 1 and Level 2 during the nine month period ended September 30, 2016.
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of September 30, 2016:
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
$
51,029

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
2.17

 
$
116.28

 
$
69.15

Collateralized loan obligations
24,292

 
Market Quotes
 
Non Binding Third-Party Valuation
 
12.25

 
434.04

 
85.10

Corporate debt and non-exchange traded corporate equity
11,928

 
Market Quotes
 
Non Binding Third-Party Valuation
 
0.40

 
115.25

 
94.79

Private label commercial mortgage-backed securities
18,636

 
Market Quotes
 
Non Binding Third-Party Valuation
 
4.84

 
70.52

 
34.36

Agency interest only residential mortgage-backed securities
18,131

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.58

 
22.52

 
10.67

Total return swaps
(1,027
)
 
Market Quotes
 
Non Binding Third-Party Valuation (1) 
 
50.70

 
100.25

 
87.07

Private label residential mortgage-backed securities
30,916

 
Discounted Cash Flows
 
Yield
 
2.0
%
 
21.5
%
 
10.6
%
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
75.4
%
 
10.6
%
 
 
 
 
 
Projected Collateral Losses
 
2.7
%
 
50.8
%
 
40.7
%
 
 
 
 
 
Projected Collateral Recoveries
 
0.0
%
 
52.6
%
 
41.8
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
62.5
%
 
6.9
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
18,309

 
Discounted Cash Flows
 
Yield
 
8.3
%
 
36.4
%
 
21.9
%
 
 
 
 
 
Projected Collateral Losses
 
0.9
%
 
4.6
%
 
2.8
%
 
 
 
 
 
Projected Collateral Recoveries
 
4.6
%
 
30.9
%
 
13.6
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
65.0
%
 
94.4
%
 
83.6
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and warrants
10,276

 
Discounted Cash Flows
 
Yield
 
16.9
%
 
16.9
%
 
16.9
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Collateralized loan obligations
$
4,111

 
Discounted Cash Flows
 
Yield
 
14.6
%
 
35.1
%
 
21.0
%
 
 
 
 
 
Projected Collateral Prepayments
 
27.9
%
 
60.0
%
 
50.3
%
 
 
 
 
 
Projected Collateral Losses
 
5.8
%
 
22.6
%
 
9.8
%
 
 
 
 
 
Projected Collateral Recoveries
 
1.5
%
 
11.3
%
 
4.7
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
28.5
%
 
50.1
%
 
35.2
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans
119,099

 
Discounted Cash Flows
 
Yield
 
7.9
%
 
24.9
%
 
10.6
%
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
42.7
%
 
34.6
%
 
 
 
 
 
Projected Collateral Losses
 
0.9
%
 
97.1
%
 
8.5
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
85.4
%
 
56.9
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
33,383

 
Discounted Cash Flows
 
Yield
 
8.0
%
 
17.2
%
 
11.2
%
Non-performing commercial mortgage loans and commercial real estate owned
25,311

 
Discounted Cash Flows
 
Yield
 
10.2
%
 
19.8
%
 
14.7
%
 
 
 
 
 
Months to Resolution
 
6.0

 
38.1

 
20.2

Performing residential mortgage loans
40,576

 
Discounted Cash Flows
 
Yield
 
4.8
%
 
14.9
%
 
6.7
%
Non-performing residential mortgage loans and residential real estate owned
5,358

 
Discounted Cash Flows
 
Yield
 
7.0
%
 
9.0
%
 
8.3
%
 
 
 
 
 
Months to Resolution
 
5.9

 
125.6

 
27.1

Credit default swaps on asset-backed securities
5,595

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
20.3
%
 
29.7
%
 
24.5
%
 
 
 
 
 
Projected Collateral Losses
 
14.9
%
 
29.2
%
 
22.9
%
 
 
 
 
 
Projected Collateral Recoveries
 
5.1
%
 
12.8
%
 
7.9
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
39.3
%
 
50.0
%
 
44.7
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded equity investments in commercial mortgage-related private partnerships
3,030

 
Discounted Cash Flows
 
Yield
 
16.5
%
 
16.5
%
 
16.5
%
 
 
 
 
 
Expected Holding Period (Months)
 
5.9

 
5.9

 
5.9

Agency interest only residential mortgage-backed securities
1,693

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(2)
 
441

 
1,220

 
692

 
 
 
 
 
Projected Collateral Prepayments
 
17.8
%
 
100.0
%
 
74.5
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
82.2
%
 
25.5
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred and common equity investment in mortgage-related entities and warrants
15,000

 
Recent Transactions
 
Transaction Price
 
N/A
 
N/A
 
N/A
Guarantees
(150
)
 
Cash Flows
 
Expected Cash Flows(3)
 
N/A
 
N/A
 
N/A
(1)
Represents valuations on underlying assets.
(2)
Shown in basis points.
(3)
Represents transactions with a remaining term of less than one year.
Third-party non-binding valuations are validated by comparing such valuations to internally generated prices based on the Company's models and to recent trading activity in the same or similar instruments.
For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread ("OAS") valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to (b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset. The Company considers the expected timeline to resolution in the determination of fair value for its non-performing commercial and residential loans.
Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, for instruments subject to prepayments and credit losses, such as non-Agency RMBS and consumer loans and ABS backed by consumer loans, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such credit default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2015:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
160,000

 
$

 
$

 
$
160,000

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
1,035,662

 
$
24,918

 
$
1,060,580

Private label residential mortgage-backed securities
 

 
138,482

 
116,435

 
254,917

Private label commercial mortgage-backed securities
 

 

 
34,145

 
34,145

Commercial mortgage loans
 

 

 
66,399

 
66,399

Residential mortgage loans
 

 

 
22,089

 
22,089

Collateralized loan obligations
 

 

 
45,974

 
45,974

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
115,376

 
115,376

Corporate debt
 

 

 
27,028

 
27,028

Real estate owned
 

 

 
12,522

 
12,522

Private corporate equity investments
 

 

 
22,088

 
22,088

Total investments, at fair value
 

 
1,174,144

 
486,974

 
1,661,118

 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 
$

 
$

 
$
6,332

 
$
6,332

Credit default swaps on corporate bond indices
 

 
137,643

 

 
137,643

Credit default swaps on corporate bonds
 

 
10

 

 
10

Credit default swaps on asset-backed indices
 

 
5,410

 

 
5,410

Interest rate swaps
 

 
9,943

 

 
9,943

Total return swaps
 

 

 
85

 
85

Options
 
112

 
2,050

 

 
2,162

Futures
 
32

 

 

 
32

Forwards
 

 
1,138

 

 
1,138

Warrants
 

 

 
150

 
150

Total financial derivatives–assets, at fair value
 
144

 
156,194

 
6,567

 
162,905

Repurchase agreements
 

 
105,700

 

 
105,700

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$
144

 
$
1,436,038

 
$
493,541

 
$
1,929,723

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(612,777
)
 
$

 
$
(612,777
)
Government debt
 

 
(114,051
)
 

 
(114,051
)
Corporate debt
 

 

 
(448
)
 
(448
)
Common stock
 
(1,471
)
 

 

 
(1,471
)
Total investments sold short, at fair value
 
(1,471
)
 
(726,828
)
 
(448
)
 
(728,747
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(47,298
)
 

 
(47,298
)
Credit default swaps on corporate bonds
 

 
(683
)
 

 
(683
)
Credit default swaps on asset-backed indices
 

 
(365
)
 

 
(365
)
Credit default swaps on asset-backed securities
 

 

 
(221
)
 
(221
)
Interest rate swaps
 

 
(4,934
)
 

 
(4,934
)
Total return swaps
 

 

 
(4,662
)
 
(4,662
)
Options
 

 
(1,760
)
 

 
(1,760
)
Futures
 
(528
)
 

 

 
(528
)
Forwards
 

 
(13
)
 

 
(13
)
Mortgage loan purchase commitments
 

 
(8
)
 

 
(8
)
Total financial derivatives–liabilities, at fair value
 
(528
)
 
(55,061
)
 
(4,883
)
 
(60,472
)
Guarantees(1)
 

 

 
(828
)
 
(828
)
Total investments sold short, financial derivatives–liabilities, and guarantees, at fair value
 
$
(1,999
)
 
$
(781,889
)
 
$
(6,159
)
 
$
(790,047
)

(1)
Included in Other liabilities on the Consolidated Statement of Assets, Liabilities, and Equity.
There were no transfers of financial instruments between Level 1 and Level 2 during the year ended December 31, 2015.
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2015:
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
$
89,549

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
1.81

 
$
151.86

 
$
68.47

Collateralized loan obligations
41,978

 
Market Quotes
 
Non Binding Third-Party Valuation
 
13.00

 
102.00

 
84.84

Corporate debt and non-exchange traded corporate equity
18,972

 
Market Quotes
 
Non Binding Third-Party Valuation
 
3.00

 
200.00

 
77.85

Private label commercial mortgage-backed securities
20,365

 
Market Quotes
 
Non Binding Third-Party Valuation
 
6.07

 
73.20

 
41.28

Agency interest only residential mortgage-backed securities
21,067

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.97

 
22.41

 
11.08

Total return swaps
(4,577
)
 
Market Quotes
 
Non Binding Third-Party Valuation (1)
 
36.38

 
99.88

 
56.38

Private label residential mortgage-backed securities
26,886

 
Discounted Cash Flows
 
Yield
 
3.4
%
 
27.1
%
 
19.9
%
 
 
 
 
 
Projected Collateral Prepayments
 
5.4
%
 
74.6
%
 
46.3
%
 
 
 
 
 
Projected Collateral Losses
 
2.9
%
 
24.5
%
 
11.4
%
 
 
 
 
 
Projected Collateral Recoveries
 
0.3
%
 
13.0
%
 
8.0
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
8.6
%
 
88.6
%
 
34.3
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
13,780

 
Discounted Cash Flows
 
Yield
 
19.2
%
 
25.0
%
 
22.1
%
 
 
 
 
 
Projected Collateral Losses
 
0.7
%
 
2.3
%
 
1.6
%
 
 
 
 
 
Projected Collateral Recoveries
 
1.5
%
 
14.3
%
 
8.4
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
83.4
%
 
97.6
%
 
90.0
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and warrants
13,920

 
Discounted Cash Flows
 
Yield
 
15.0
%
 
20.0
%
 
16.2
%
Collateralized loan obligations
3,996

 
Discounted Cash Flows
 
Yield
 
8.3
%
 
20.6
%
 
13.5
%
 
 
 
 
 
Projected Collateral Prepayments
 
31.9
%
 
52.3
%
 
41.1
%
 
 
 
 
 
Projected Collateral Losses
 
2.6
%
 
17.3
%
 
12.9
%
 
 
 
 
 
Projected Collateral Recoveries
 
2.3
%
 
15.5
%
 
10.1
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
33.3
%
 
51.5
%
 
35.9
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans(2)
115,376

 
Discounted Cash Flows
 
Yield
 
9.0
%
 
15.0
%
 
10.4
%
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
40.9
%
 
30.9
%
 
 
 
 
 
Projected Collateral Losses
 
1.0
%
 
33.8
%
 
7.3
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
57.3
%
 
80.8
%
 
61.8
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
43,847

 
Discounted Cash Flows
 
Yield
 
9.8
%
 
17.6
%
 
11.9
%
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Non-performing commercial mortgage loans and commercial real estate owned
$
30,984

 
Discounted Cash Flows
 
Yield
 
10.2
%
 
19.4
%
 
13.7
%
 
 
 
 
 
Months to Resolution
 
4.0

 
24.0

 
9.3

Performing residential mortgage loans
13,848

 
Discounted Cash Flows
 
Yield
 
5.5
%
 
8.0
%
 
6.5
%
Non-performing residential mortgage loans and residential real estate owned
12,331

 
Discounted Cash Flows
 
Yield
 
5.7
%
 
7.9
%
 
7.3
%
 
 
 
 
 
Months to Resolution
 
3.4

 
113.6

 
20.6

Credit default swaps on asset-backed securities
6,111

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
26.6
%
 
44.1
%
 
32.6
%
 
 
 
 
 
Projected Collateral Losses
 
15.0
%
 
33.7
%
 
26.5
%
 
 
 
 
 
Projected Collateral Recoveries
 
6.8
%
 
16.9
%
 
12.0
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
24.5
%
 
33.1
%
 
28.9
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred equity investment in commercial mortgage-related private partnership
10,558

 
Discounted Cash Flows
 
Yield
 
14.0
%
 
16.5
%
 
14.7
%
 
 
 
 
 
Expected Holding Period (Months)
 
14.3

 
27.0

 
23.5

Agency interest only residential mortgage-backed securities
3,851

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(2)
 
441

 
1,672

 
622

 
 
 
 
 
Projected Collateral Prepayments
 
18.0
%
 
100.0
%
 
70.4
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
82.0
%
 
29.6
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred and common equity investment in mortgage-related entities
2,738

 
Enterprise Value
 
Equity Multiple(3)
 
2.7x

 
2.7x

 
2.7x

Non-exchange traded preferred and common equity investment in mortgage-related entities
2,630

 
Recent Transactions
 
Transaction Price
 
N/A

 
N/A

 
N/A

Guarantees
(828
)
 
Cash Flows
 
Expected Cash Flows(4)
 
N/A

 
N/A

 
N/A

(1)
Represents valuations on underlying assets.
(2)
Shown in basis points.
(3)
Represent an estimation of where market participants might value an enterprise.
(4)
Represents transactions with a remaining term of less than one year.
Third-party non-binding valuations are validated by comparing such valuations to internally generated prices based on the Company's models and to recent trading activity in the same or similar instruments.
For those instruments valued using discounted and net discounted cash flows, collateral prepayments, losses, recoveries, and scheduled amortization are projected over the remaining life of the collateral and expressed as a percentage of the collateral's current principal balance. Averages are weighted based on the fair value of the related instrument. In the case of credit default swaps on asset-backed securities, averages are weighted based on each instrument's bond equivalent value. Bond equivalent value represents the investment amount of a corresponding position in the reference obligation, calculated as the difference between the outstanding principal balance of the underlying reference obligation and the fair value, inclusive of accrued interest, of the derivative contract. For those assets valued using the LIBOR Option Adjusted Spread valuation methodology, cash flows are projected using the Company's models over multiple interest rate scenarios, and these projected cash flows are then discounted using the LIBOR rates implied by each interest rate scenario. The LIBOR OAS of an asset is then computed as the unique constant yield spread that, when added to all LIBOR rates in each interest rate scenario generated by the model, will equate (a) the expected present value of the projected asset cash flows over all model scenarios to (b) the actual current market price of the asset. LIBOR OAS is therefore model-dependent. Generally speaking, LIBOR OAS measures the additional yield spread over LIBOR that an asset provides at its current market price after taking into account any interest rate options embedded in the asset.
Material changes in any of the inputs above in isolation could result in a significant change to reported fair value measurements. Additionally, fair value measurements are impacted by the interrelationships of these inputs. For example, a higher expectation of collateral prepayments will generally be accompanied by a lower expectation of collateral losses. Conversely, higher losses will generally be accompanied by lower prepayments. Because the Company's credit default swaps on asset-backed security holdings represent credit default swap contracts whereby the Company has purchased credit protection, such default swaps on asset-backed securities generally have the directionally opposite sensitivity to prepayments, losses, and recoveries as compared to the Company's long securities holdings. Prepayments do not represent a significant input for the Company's commercial mortgage-backed securities and commercial mortgage loans. Losses and recoveries do not represent a significant input for the Company's Agency RMBS interest only securities, given the guarantee of the issuing government agency or government-sponsored enterprise.
The tables below include a roll-forward of the Company's financial instruments for the three and nine month periods ended September 30, 2016 and 2015 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Three Month Period Ended September 30, 2016
(In thousands)
Ending
Balance as of 
June 30, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
September 30, 2016
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
20,506

 
$
(1,821
)
 
$
(77
)
 
$
(169
)
 
$
1,385

 
$

 
$

 
$

 
$
19,824

Private label residential mortgage-backed securities
112,511

 
256

 
(958
)
 
6,086

 

 
(23,652
)
 
1,517

 
(13,815
)
 
81,945

Private label commercial mortgage-backed securities
34,942

 
429

 
87

 
(292
)
 
5,335

 
(3,556
)
 

 

 
36,945

Commercial mortgage loans
49,466

 
801

 
72

 
(1,140
)
 
13,226

 
(5,456
)
 

 

 
56,969

Residential mortgage loans
46,649

 
67

 
(78
)
 
(66
)
 
24,002

 
(26,499
)
 

 

 
44,075

Collateralized loan obligations
33,109

 
(890
)
 
(703
)
 
2,844

 
4,241

 
(10,198
)
 

 

 
28,403

Consumer loans and asset-backed securities backed by consumer loans
154,395

 
(2,919
)
 
204

 
(2,290
)
 
51,775

 
(82,066
)
 

 

 
119,099

Corporate debt
36,974

 
(52
)
 
(1,942
)
 
3,753

 
83,700

 
(66,116
)
 

 

 
56,317

Real estate owned
4,162

 

 
53

 
(214
)
 
1,942

 
(2,359
)
 

 

 
3,584

Private corporate equity investments
19,418

 

 
733

 
349

 
5,100

 
(10,082
)
 

 

 
15,518

Total investments, at fair value
512,132

 
(4,129
)
 
(2,609
)
 
8,861

 
190,706

 
(229,984
)
 
1,517

 
(13,815
)
 
462,679

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
6,068

 

 
604

 
(221
)
 
65

 
(659
)
 

 

 
5,857

Total return swaps
824

 

 
3,222

 
(628
)
 
954

 
(4,176
)
 

 

 
196

Warrants
100

 

 

 

 
7,486

 

 

 

 
7,586

Total financial derivatives– assets, at fair value
6,992

 

 
3,826

 
(849
)
 
8,505

 
(4,835
)
 

 

 
13,639

Total investments and financial derivatives–assets, at fair value
$
519,124

 
$
(4,129
)
 
$
1,217

 
$
8,012

 
$
199,211

 
$
(234,819
)
 
$
1,517

 
$
(13,815
)
 
$
476,318

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments sold short, at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
$
(9,947
)
 
$

 
$
(122
)
 
$
(7
)
 
$
20,974

 
$
(50,085
)
 
$

 
$

 
$
(39,187
)
Total investments sold short, at fair value
(9,947
)
 

 
(122
)
 
(7
)
 
20,974

 
(50,085
)
 

 

 
(39,187
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
Ending
Balance as of 
June 30, 2016
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
September 30, 2016
(continued)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(234
)
 
$

 
$
18

 
$
(67
)
 
$
47

 
$
(26
)
 
$

 
$

 
$
(262
)
Total return swaps
(1,016
)
 

 
(2,143
)
 
(207
)
 
1,890

 
253

 

 

 
(1,223
)
Total financial derivatives– liabilities, at fair value
(1,250
)
 

 
(2,125
)
 
(274
)
 
1,937

 
227

 

 

 
(1,485
)
Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees
(312
)
 

 

 
162

 

 

 

 

 
(150
)
Total guarantees
(312
)
 

 

 
162

 

 

 

 

 
(150
)
Total investments sold short, financial derivatives– liabilities, and guarantees, at fair value
$
(11,509
)
 
$

 
$
(2,247
)
 
$
(119
)
 
$
22,911

 
$
(49,858
)
 
$

 
$

 
$
(40,822
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2016, as well as Level 3 financial instruments disposed of by the Company during the three month period ended September 30, 2016. For Level 3 financial instruments held by the Company at September 30, 2016, change in net unrealized gain (loss) of $0.6 million, $(34) thousand, $0.4 million, $(1.1) million, and $0.2 million, for the three month period ended September 30, 2016 relate to investments, investments sold short, financial derivatives–assets, financial derivatives–liabilities, and guarantees, respectively.
During the three month period ended September 30, 2016, the Company transferred $13.8 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, during the three month period ended September 30, 2016, the Company transferred $1.5 million of non-Agency RMBS from Level 2 to Level 3. Since June 30, 2016, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.
Three Month Period Ended September 30, 2015
(In thousands)
Ending
Balance as of 
June 30, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
September 30, 2015
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
30,385

 
$
(2,249
)
 
$

 
$
(1,135
)
 
$
1,354

 
$

 
$

 
$

 
$
28,355

Private label residential mortgage-backed securities
160,046

 
2,682

 
4,139

 
(5,191
)
 
10,138

 
(27,217
)
 
20,154

 
(14,294
)
 
150,457

Private label commercial mortgage-backed securities
49,834

 
579

 
25

 
(151
)
 
1,250

 
(9,022
)
 

 

 
42,515

Commercial mortgage loans
55,310

 
(2
)
 
543

 
(192
)
 
4,305

 
(5,344
)
 

 

 
54,620

Residential mortgage loans
20,929

 
279

 
714

 
(9
)
 
3,902

 
(8,156
)
 

 

 
17,659

Collateralized loan obligations
98,388

 
(4,862
)
 
2,581

 
(2,678
)
 
5,946

 
(42,572
)
 

 

 
56,803

Consumer loans and asset-backed securities backed by consumer loans
52,457

 
(1,413
)
 

 
180

 
43,830

 
(17,353
)
 

 

 
77,701

Corporate debt
26,278

 
75

 
(28
)
 
(3,212
)
 
9,609

 
(4,475
)
 

 

 
28,247

Real estate owned
9,502

 

 
437

 
(299
)
 
8,007

 
(2,817
)
 

 

 
14,830

Private corporate equity investments
22,349

 

 

 
(285
)
 

 
(58
)
 

 

 
22,006

Total investments, at fair value
525,478

 
(4,911
)
 
8,411

 
(12,972
)
 
88,341

 
(117,014
)
 
20,154

 
(14,294
)
 
493,193

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
9,449

 

 
446

 
(310
)
 
10

 
(668
)
 

 

 
8,927

Total return swaps
247

 

 
51

 
(71
)
 
18

 
(69
)
 

 

 
176

Warrants
100

 

 

 

 

 

 

 

 
100

Total financial derivatives– assets, at fair value
9,796

 

 
497

 
(381
)
 
28

 
(737
)
 

 

 
9,203

Total investments and financial derivatives–assets, at fair value
$
535,274

 
$
(4,911
)
 
$
8,908

 
$
(13,353
)
 
$
88,369

 
$
(117,751
)
 
$
20,154

 
$
(14,294
)
 
$
502,396

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(280
)
 
$

 
$
(18
)
 
$
18

 
$

 
$
18

 
$

 
$

 
$
(262
)
Total return swaps
(1,903
)
 

 
854

 
(1,152
)
 
(869
)
 
15

 

 

 
(3,055
)
Total financial derivatives– liabilities, at fair value
(2,183
)
 

 
836

 
(1,134
)
 
(869
)
 
33

 

 

 
(3,317
)
Securitized debt:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securitized debt
(655
)
 
(3
)
 

 
1

 
154

 

 

 

 
(503
)
Total securitized debt
(655
)
 
(3
)
 

 
1

 
154

 

 

 

 
(503
)
Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees
(13
)
 

 

 
(1,216
)
 

 

 

 

 
(1,229
)
Total guarantees
(13
)
 

 

 
(1,216
)
 

 

 

 

 
(1,229
)
Total financial derivatives– liabilities and securitized debt, and guarantees, at fair value
$
(2,851
)
 
$
(3
)
 
$
836

 
$
(2,349
)
 
$
(715
)
 
$
33

 
$

 
$

 
$
(5,049
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2015, as well as Level 3 financial instruments disposed of by the Company during the three month period ended September 30, 2015. For Level 3 financial instruments held by the Company at September 30, 2015, change in net unrealized gain (loss) of $(11.8) million, $(0.3) million, $(1.3) million, $1 thousand, and $(1.2) million, for the three month period ended September 30, 2015 relate to investments, financial derivatives–assets, financial derivatives–liabilities, securitized debt, and guarantees, respectively.
During the three month period ended September 30, 2015, the Company transferred $14.3 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, during the three month period ended September 30, 2015, the Company transferred $20.2 million of non-Agency RMBS from Level 2 to Level 3. These securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.
Nine Month Period Ended September 30, 2016
(In thousands)
Ending
Balance as of 
December 31, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
September 30, 2016
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
24,918

 
$
(5,766
)
 
$
(168
)
 
$
(849
)
 
$
1,689

 
$

 
$

 
$

 
$
19,824

Private label residential mortgage-backed securities
116,435

 
1,518

 
(1,305
)
 
2,995

 
7,439

 
(34,904
)
 
8,360

 
(18,593
)
 
81,945

Private label commercial mortgage-backed securities
34,145

 
1,315

 
409

 
(4,132
)
 
13,179

 
(7,971
)
 

 

 
36,945

Commercial mortgage loans
66,399

 
2,073

 
254

 
(917
)
 
26,650

 
(37,490
)
 

 

 
56,969

Residential mortgage loans
22,089

 
315

 
787

 
61

 
56,068

 
(35,245
)
 

 

 
44,075

Collateralized loan obligations
45,974

 
(3,759
)
 
98

 
3,261

 
5,418

 
(22,589
)
 

 

 
28,403

Consumer loans and asset-backed securities backed by consumer loans
115,376

 
(8,515
)
 
210

 
(2,839
)
 
140,731

 
(125,864
)
 

 

 
119,099

Corporate debt
27,028

 
(99
)
 
(1,687
)
 
1,652

 
136,020

 
(106,597
)
 

 

 
56,317

Real estate owned
12,522

 

 
2,291

 
(545
)
 
12,614

 
(23,298
)
 

 

 
3,584

Private corporate equity investments
22,088

 

 
704

 
(182
)
 
11,617

 
(18,709
)
 

 

 
15,518

Total investments, at fair value
486,974

 
(12,918
)
 
1,593

 
(1,495
)
 
411,425

 
(412,667
)
 
8,360

 
(18,593
)
 
462,679

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
6,332

 

 
1,068

 
(476
)
 
77

 
(1,144
)
 

 

 
5,857

Total return swaps
85

 

 
3,119

 
111

 
1,377

 
(4,496
)
 

 

 
196

Warrants
150

 

 
(50
)
 

 
7,486

 

 

 

 
7,586

Total financial derivatives– assets, at fair value
6,567

 

 
4,137

 
(365
)
 
8,940

 
(5,640
)
 

 

 
13,639

Total investments and financial derivatives–assets, at fair value
$
493,541

 
$
(12,918
)
 
$
5,730

 
$
(1,860
)
 
$
420,365

 
$
(418,307
)
 
$
8,360

 
$
(18,593
)
 
$
476,318

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments sold short, at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
$
(448
)
 
$
(8
)
 
$
409

 
$
(566
)
 
$
32,230

 
$
(70,804
)
 
$

 
$

 
$
(39,187
)
Total investments sold short, at fair value
(448
)
 
(8
)
 
409

 
(566
)
 
32,230

 
(70,804
)
 

 

 
(39,187
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
Ending
Balance as of 
December 31, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
September 30, 2016
(continued)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(221
)
 
$

 
$
(61
)
 
$
(42
)
 
$
47

 
$
15

 
$

 
$

 
$
(262
)
Total return swaps
(4,662
)
 

 
(6,508
)
 
3,438

 
6,576

 
(67
)
 

 

 
(1,223
)
Total financial derivatives– liabilities, at fair value
(4,883
)
 

 
(6,569
)
 
3,396

 
6,623

 
(52
)
 

 

 
(1,485
)
Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees
(828
)
 

 

 
678

 

 

 

 

 
(150
)
Total guarantees
(828
)
 

 

 
678

 

 

 

 

 
(150
)
Total investments sold short, financial derivatives– liabilities, and guarantees, at fair value
$
(6,159
)
 
$
(8
)
 
$
(6,160
)
 
$
3,508

 
$
38,853

 
$
(70,856
)
 
$

 
$

 
$
(40,822
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2016, as well as Level 3 financial instruments disposed of by the Company during the nine month period ended September 30, 2016. For Level 3 financial instruments held by the Company at September 30, 2016, change in net unrealized gain (loss) of $(10.4) million, $(0.3) million, $(0.3) million, $(1.2) million, and $0.7 million, for the nine month period ended September 30, 2016 relate to investments, investments sold short, financial derivatives–assets, financial derivatives–liabilities, and guarantees, respectively.
During the nine month period ended September 30, 2016, the Company transferred $18.6 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, during the nine month period ended September 30, 2016, the Company transferred $8.4 million of non-Agency RMBS from Level 2 to Level 3. Since December 31, 2015, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.
Nine Month Period Ended September 30, 2015
(In thousands)
Ending
Balance as of December 31, 2014
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
September 30, 2015
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
31,385

 
$
(6,196
)
 
$
472

 
$
373

 
$
8,860

 
$
(6,539
)
 
$

 
$

 
$
28,355

Private label residential mortgage-backed securities
274,369

 
7,524

 
16,855

 
(11,589
)
 
64,366

 
(163,848
)
 
9,667

 
(46,887
)
 
150,457

Private label commercial mortgage-backed securities
53,311

 
2,507

 
549

 
(2,844
)
 
21,382

 
(32,390
)
 

 

 
42,515

Commercial mortgage loans
28,309

 
1,273

 
542

 
(812
)
 
55,115

 
(29,807
)
 

 

 
54,620

Residential mortgage loans
27,482

 
1,127

 
2,378

 
(80
)
 
13,660

 
(26,908
)
 

 

 
17,659

Collateralized loan obligations
123,338

 
(9,335
)
 
2,533

 
(4,131
)
 
55,533

 
(111,135
)
 

 

 
56,803

Consumer loans and asset-backed securities backed by consumer loans
22,950

 
(4,832
)
 

 
956

 
84,969

 
(26,342
)
 

 

 
77,701

Corporate debt
42,708

 
121

 
80

 
(5,601
)
 
22,239

 
(31,300
)
 

 

 
28,247

Real estate owned
8,635

 

 
685

 
228

 
13,252

 
(7,970
)
 

 

 
14,830

Private corporate equity investments
14,512

 

 
116

 
213

 
7,689

 
(524
)
 

 

 
22,006

Total investments, at fair value
626,999

 
(7,811
)
 
24,210

 
(23,287
)
 
347,065

 
(436,763
)
 
9,667

 
(46,887
)
 
493,193

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
11,387

 
$

 
$
(717
)
 
$
392

 
$
35

 
$
(2,170
)
 
$

 
$

 
$
8,927

Total return swaps

 

 
336

 
176

 
39

 
(375
)
 

 

 
176

Warrants
100

 

 

 

 

 

 

 

 
100

Total financial derivatives– assets, at fair value
11,487

 

 
(381
)
 
568

 
74

 
(2,545
)
 

 

 
9,203

Total investments and financial derivatives–assets, at fair value
$
638,486

 
$
(7,811
)
 
$
23,829

 
$
(22,719
)
 
$
347,139

 
$
(439,308
)
 
$
9,667

 
$
(46,887
)
 
$
502,396

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives– liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(239
)
 
$

 
$
(60
)
 
$
(23
)
 
$

 
$
60

 
$

 
$

 
$
(262
)
Total return swaps

 

 
1,207

 
(3,054
)
 
(1,223
)
 
15

 

 

 
(3,055
)
Total financial derivatives– liabilities, at fair value
(239
)
 

 
1,147

 
(3,077
)
 
(1,223
)
 
75

 

 

 
(3,317
)
Securitized debt:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securitized debt
(774
)
 
(5
)
 

 
21

 
255

 

 

 

 
(503
)
Total securitized debt
(774
)
 
(5
)
 

 
21

 
255

 

 

 

 
(503
)
Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees

 

 

 
(1,229
)
 

 

 

 

 
(1,229
)
Total guarantees

 

 

 
(1,229
)
 

 

 

 

 
(1,229
)
Total financial derivatives– liabilities and securitized debt, at fair value
$
(1,013
)
 
$
(5
)
 
$
1,147

 
$
(4,285
)
 
$
(968
)
 
$
75

 
$

 
$

 
$
(5,049
)

All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at September 30, 2015, as well as Level 3 financial instruments disposed of by the Company during the nine month period ended September 30, 2015. For Level 3 financial instruments held by the Company at September 30, 2015, change in net unrealized gain (loss) of $(21.8) million, $(71) thousand, $(3.0) million, $21 thousand, and $(1.2) million, for the nine month period ended September 30, 2015 relate to investments, financial derivatives–assets, financial derivatives–liabilities, securitized debt, and guarantees, respectively.
During the nine month period ended September 30, 2015, the Company transferred $46.9 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, during the nine month period ended September 30, 2015, the Company transferred $9.7 million of non-Agency RMBS from Level 2 to Level 3. Following December 2014, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.